Harsh Amin is an R&D leader in the Biotechnology/Biopharma industry with over 15 years of experience. He has a track record of translating scientific discoveries into commercial setups and has worked in startups (ReNeuron, Evox Therapeutics Ltd) and a corporate pharmaceutical giant (Lonza). Harsh has successfully built high-performing cross-disciplinary R&D organizations and conducted research on stem cell biology at University College London & Imperial College London, focusing on musculoskeletal disorders and regenerative medicine. His expertise includes stem cell biology, regenerative medicine, translational medicine, CHO biology, cell culture media development, exosome research, cell line development, musculoskeletal diseases, cell biology, analytical sciences, and clinical product development. Outside of work, Harsh enjoys playing cricket with his two young children, both avid fans of Indian and English cricket teams.